Dyne Therapeutics, Inc. DYN Weighted Average Limited Partnership Units Outstanding Diluted
Weighted Average Limited Partnership Units Outstanding Diluted at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageLimitedPartnershipUnitsOutstandingDiluted.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted?
- Dyne Therapeutics, Inc. (DYN) reported weighted average limited partnership units outstanding diluted of 165M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted changed year-over-year?
- Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted increased by 50.2% year-over-year, from 109.9M to 165M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted?
- Over 3 years (2022 to 2025), Dyne Therapeutics, Inc.'s weighted average limited partnership units outstanding diluted has grown at a 33.6% compound annual growth rate (CAGR), from 207.1M to 494M.
- What does weighted average limited partnership units outstanding diluted mean?
- This metric represents the weighted average number of limited partnership units outstanding during the period, adjusted for the dilutive effect of all potential units such as options, warrants, or convertible securities. It is used to calculate diluted earnings per unit, providing a conservative view of potential earnings dilution. Investors use this to assess the impact of future equity issuance on existing unit holder value.